Intrinsic value of Cutera - CUTR

Previous Close

$43.50

  Intrinsic Value

$80.70

stock screener

  Rating & Target

str. buy

+86%

Previous close

$43.50

 
Intrinsic value

$80.70

 
Up/down potential

+86%

 
Rating

str. buy

We calculate the intrinsic value of CUTR stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Shares outstanding, mln

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  24.21
  28.30
  25.97
  23.87
  21.99
  20.29
  18.76
  17.38
  16.14
  15.03
  14.03
  13.12
  12.31
  11.58
  10.92
  10.33
  9.80
  9.32
  8.89
  8.50
  8.15
  7.83
  7.55
  7.29
  7.07
  6.86
  6.67
  6.51
  6.35
  6.22
  6.10
Revenue, $m
  118
  194
  244
  302
  369
  444
  527
  618
  718
  826
  942
  1,066
  1,197
  1,335
  1,481
  1,634
  1,794
  1,962
  2,136
  2,317
  2,506
  2,703
  2,907
  3,119
  3,339
  3,568
  3,806
  4,054
  4,311
  4,579
  4,859
Variable operating expenses, $m
 
  143
  180
  223
  272
  328
  389
  457
  530
  610
  696
  787
  884
  986
  1,094
  1,207
  1,325
  1,448
  1,577
  1,711
  1,850
  1,995
  2,146
  2,303
  2,465
  2,634
  2,810
  2,993
  3,183
  3,381
  3,587
Fixed operating expenses, $m
 
  31
  31
  32
  33
  33
  34
  35
  36
  36
  37
  38
  39
  40
  41
  42
  42
  43
  44
  45
  46
  47
  48
  49
  51
  52
  53
  54
  55
  56
  58
Total operating expenses, $m
  116
  174
  211
  255
  305
  361
  423
  492
  566
  646
  733
  825
  923
  1,026
  1,135
  1,249
  1,367
  1,491
  1,621
  1,756
  1,896
  2,042
  2,194
  2,352
  2,516
  2,686
  2,863
  3,047
  3,238
  3,437
  3,645
Operating income, $m
  2
  20
  32
  47
  64
  83
  104
  127
  152
  180
  209
  241
  274
  310
  347
  386
  427
  470
  515
  561
  609
  660
  712
  767
  823
  882
  943
  1,007
  1,073
  1,142
  1,214
EBITDA, $m
  3
  20
  33
  48
  65
  84
  105
  128
  154
  181
  211
  243
  277
  313
  350
  390
  431
  474
  519
  566
  615
  666
  719
  773
  830
  890
  951
  1,016
  1,082
  1,152
  1,224
Interest expense (income), $m
  0
  0
  1
  2
  3
  4
  5
  6
  8
  9
  11
  13
  15
  17
  20
  22
  25
  27
  30
  33
  36
  39
  42
  46
  49
  53
  56
  60
  65
  69
  73
Earnings before tax, $m
  3
  20
  32
  45
  61
  79
  99
  121
  144
  170
  198
  228
  259
  292
  327
  364
  403
  443
  485
  528
  574
  621
  670
  721
  774
  829
  887
  946
  1,008
  1,073
  1,140
Tax expense, $m
  0
  5
  9
  12
  17
  21
  27
  33
  39
  46
  53
  61
  70
  79
  88
  98
  109
  120
  131
  143
  155
  168
  181
  195
  209
  224
  239
  255
  272
  290
  308
Net income, $m
  3
  15
  23
  33
  45
  58
  72
  88
  105
  124
  144
  166
  189
  213
  239
  266
  294
  323
  354
  386
  419
  453
  489
  526
  565
  605
  647
  691
  736
  783
  833

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  54
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  92
  142
  179
  222
  271
  326
  387
  454
  527
  607
  692
  782
  879
  981
  1,088
  1,200
  1,318
  1,440
  1,568
  1,702
  1,840
  1,984
  2,134
  2,290
  2,452
  2,620
  2,794
  2,976
  3,165
  3,362
  3,567
Adjusted assets (=assets-cash), $m
  38
  142
  179
  222
  271
  326
  387
  454
  527
  607
  692
  782
  879
  981
  1,088
  1,200
  1,318
  1,440
  1,568
  1,702
  1,840
  1,984
  2,134
  2,290
  2,452
  2,620
  2,794
  2,976
  3,165
  3,362
  3,567
Revenue / Adjusted assets
  3.105
  1.366
  1.363
  1.360
  1.362
  1.362
  1.362
  1.361
  1.362
  1.361
  1.361
  1.363
  1.362
  1.361
  1.361
  1.362
  1.361
  1.363
  1.362
  1.361
  1.362
  1.362
  1.362
  1.362
  1.362
  1.362
  1.362
  1.362
  1.362
  1.362
  1.362
Average production assets, $m
  2
  4
  5
  7
  8
  10
  12
  14
  16
  18
  21
  23
  26
  29
  33
  36
  39
  43
  47
  51
  55
  59
  64
  69
  73
  78
  84
  89
  95
  101
  107
Working capital, $m
  60
  28
  35
  44
  53
  64
  76
  89
  103
  119
  136
  153
  172
  192
  213
  235
  258
  282
  308
  334
  361
  389
  419
  449
  481
  514
  548
  584
  621
  659
  700
Total debt, $m
  0
  13
  28
  46
  67
  90
  115
  143
  174
  207
  242
  280
  320
  363
  407
  454
  503
  554
  608
  663
  721
  781
  844
  909
  976
  1,046
  1,119
  1,195
  1,274
  1,356
  1,441
Total liabilities, $m
  31
  59
  75
  93
  113
  136
  161
  189
  220
  253
  288
  326
  366
  409
  454
  500
  549
  601
  654
  710
  767
  827
  890
  955
  1,022
  1,092
  1,165
  1,241
  1,320
  1,402
  1,488
Total equity, $m
  61
  83
  104
  129
  158
  190
  225
  265
  307
  354
  403
  456
  512
  572
  634
  700
  768
  840
  914
  992
  1,073
  1,157
  1,244
  1,335
  1,429
  1,527
  1,629
  1,735
  1,845
  1,960
  2,080
Total liabilities and equity, $m
  92
  142
  179
  222
  271
  326
  386
  454
  527
  607
  691
  782
  878
  981
  1,088
  1,200
  1,317
  1,441
  1,568
  1,702
  1,840
  1,984
  2,134
  2,290
  2,451
  2,619
  2,794
  2,976
  3,165
  3,362
  3,568
Debt-to-equity ratio
  0.000
  0.160
  0.270
  0.360
  0.420
  0.470
  0.510
  0.540
  0.560
  0.580
  0.600
  0.610
  0.630
  0.630
  0.640
  0.650
  0.660
  0.660
  0.660
  0.670
  0.670
  0.680
  0.680
  0.680
  0.680
  0.680
  0.690
  0.690
  0.690
  0.690
  0.690
Adjusted equity ratio
  0.184
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583
  0.583

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  3
  15
  23
  33
  45
  58
  72
  88
  105
  124
  144
  166
  189
  213
  239
  266
  294
  323
  354
  386
  419
  453
  489
  526
  565
  605
  647
  691
  736
  783
  833
Depreciation, amort., depletion, $m
  1
  1
  1
  1
  1
  1
  1
  1
  2
  2
  2
  2
  3
  3
  3
  4
  4
  4
  5
  5
  6
  6
  6
  7
  7
  8
  8
  9
  9
  10
  11
Funds from operations, $m
  -3
  15
  24
  34
  46
  59
  73
  89
  107
  126
  147
  169
  192
  216
  242
  269
  298
  327
  358
  391
  424
  459
  495
  533
  572
  613
  656
  700
  746
  793
  843
Change in working capital, $m
  -5
  6
  7
  8
  10
  11
  12
  13
  14
  16
  17
  18
  19
  20
  21
  22
  23
  24
  25
  26
  27
  28
  29
  31
  32
  33
  34
  36
  37
  39
  40
Cash from operations, $m
  2
  9
  17
  26
  36
  48
  61
  76
  93
  111
  130
  151
  173
  196
  221
  247
  275
  303
  333
  365
  397
  431
  466
  503
  541
  580
  621
  664
  709
  755
  803
Maintenance CAPEX, $m
  0
  0
  0
  -1
  -1
  -1
  -1
  -1
  -1
  -2
  -2
  -2
  -2
  -3
  -3
  -3
  -4
  -4
  -4
  -5
  -5
  -6
  -6
  -6
  -7
  -7
  -8
  -8
  -9
  -9
  -10
New CAPEX, $m
  -1
  -1
  -1
  -1
  -1
  -2
  -2
  -2
  -2
  -2
  -3
  -3
  -3
  -3
  -3
  -3
  -4
  -4
  -4
  -4
  -4
  -4
  -4
  -5
  -5
  -5
  -5
  -5
  -6
  -6
  -6
Cash from investing activities, $m
  -3
  -1
  -1
  -2
  -2
  -3
  -3
  -3
  -3
  -4
  -5
  -5
  -5
  -6
  -6
  -6
  -8
  -8
  -8
  -9
  -9
  -10
  -10
  -11
  -12
  -12
  -13
  -13
  -15
  -15
  -16
Free cash flow, $m
  -1
  8
  15
  24
  34
  45
  59
  73
  89
  107
  126
  146
  168
  191
  215
  241
  268
  296
  325
  356
  388
  421
  456
  492
  529
  568
  608
  650
  694
  739
  787
Issuance/(repayment) of debt, $m
  0
  13
  15
  18
  20
  23
  25
  28
  31
  33
  35
  38
  40
  42
  45
  47
  49
  51
  53
  56
  58
  60
  62
  65
  67
  70
  73
  76
  79
  82
  85
Issuance/(repurchase) of shares, $m
  5
  3
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  4
  16
  15
  18
  20
  23
  25
  28
  31
  33
  35
  38
  40
  42
  45
  47
  49
  51
  53
  56
  58
  60
  62
  65
  67
  70
  73
  76
  79
  82
  85
Total cash flow (excl. dividends), $m
  3
  24
  30
  42
  54
  68
  84
  101
  120
  140
  161
  184
  208
  233
  260
  288
  317
  347
  379
  411
  446
  481
  518
  557
  596
  638
  681
  726
  773
  822
  872
Retained Cash Flow (-), $m
  -11
  -18
  -22
  -25
  -28
  -32
  -36
  -39
  -43
  -46
  -50
  -53
  -56
  -59
  -62
  -66
  -69
  -72
  -75
  -78
  -81
  -84
  -87
  -91
  -94
  -98
  -102
  -106
  -110
  -115
  -120
Prev. year cash balance distribution, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  5
  7
  8
  10
  13
  15
  18
  21
  24
  28
  32
  36
  41
  45
  50
  56
  61
  67
  73
  79
  85
  92
  99
  106
  114
  121
  129
  138
  147
  156
Cash available for distribution, $m
 
  6
  9
  17
  26
  36
  48
  62
  77
  94
  111
  131
  152
  174
  197
  222
  248
  275
  304
  334
  365
  397
  431
  466
  502
  540
  579
  620
  663
  707
  753
Discount rate, %
 
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
 
  6
  8
  14
  21
  28
  35
  42
  48
  54
  58
  62
  65
  66
  66
  65
  63
  60
  56
  51
  46
  41
  36
  31
  26
  21
  17
  13
  10
  8
  6
Current shareholders' claim on cash, %
  100
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4
  99.4

Cutera, Inc. is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers. Each of its laser and other energy-based platforms consists of one or more hand pieces and a console that incorporates a universal graphical user interface, a laser or other energy-based module, control system software and high voltage electronics. The Company also offers products, such as CoolGlide that includes CV, Excel and Vantage; Solera that includes Titan S, ProWave 770, OPS 600, LP560, AcuTip 500, Titan V/XL and LimeLight, and a third-party sourced system, myQ for the Japanese market.

FINANCIAL RATIOS  of  Cutera (CUTR)

Valuation Ratios
P/E Ratio 199.7
Price to Sales 5.1
Price to Book 9.8
Price to Tangible Book
Price to Cash Flow 299.5
Price to Free Cash Flow 599
Growth Rates
Sales Growth Rate 24.2%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 0%
Cap. Spend. - 3 Yr. Gr. Rate 0%
Financial Strength
Quick Ratio NaN
Current Ratio 0
LT Debt to Equity 0%
Total Debt to Equity 0%
Interest Coverage 0
Management Effectiveness
Return On Assets 3.5%
Ret/ On Assets - 3 Yr. Avg. -3.6%
Return On Total Capital 5.4%
Ret/ On T. Cap. - 3 Yr. Avg. -4.7%
Return On Equity 5.4%
Return On Equity - 3 Yr. Avg. -4.7%
Asset Turnover 1.4
Profitability Ratios
Gross Margin 57.6%
Gross Margin - 3 Yr. Avg. 56.5%
EBITDA Margin 3.4%
EBITDA Margin - 3 Yr. Avg. -3.8%
Operating Margin 1.7%
Oper. Margin - 3 Yr. Avg. -5.5%
Pre-Tax Margin 2.5%
Pre-Tax Margin - 3 Yr. Avg. -4.8%
Net Profit Margin 2.5%
Net Profit Margin - 3 Yr. Avg. -5.3%
Effective Tax Rate 0%
Eff/ Tax Rate - 3 Yr. Avg. -3.3%
Payout Ratio 0%

CUTR stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the CUTR stock intrinsic value calculation we used $151 million for the last fiscal year's total revenue generated by Cutera. The default revenue input number comes from 2016 income statement of Cutera. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our CUTR stock valuation model: a) initial revenue growth rate of 28.3% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for CUTR is calculated based on our internal credit rating of Cutera, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Cutera.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of CUTR stock the variable cost ratio is equal to 73.9%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $30 million in the base year in the intrinsic value calculation for CUTR stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Cutera.

Corporate tax rate of 27% is the nominal tax rate for Cutera. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the CUTR stock is equal to 3.4%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for CUTR are equal to 2.2%.

Life of production assets of 10 years is the average useful life of capital assets used in Cutera operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for CUTR is equal to 14.4%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $65 million for Cutera - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 14 million for Cutera is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Cutera at the current share price and the inputted number of shares is $0.6 billion.

RELATED COMPANIES Price Int.Val. Rating

COMPANY NEWS

▶ Cutera, Inc. to Announce Second Quarter 2018 Results   [Jul-12-18 08:30AM  GlobeNewswire]
▶ Is Cutera Incs (NASDAQ:CUTR) ROE Of 42.71% Sustainable?   [Jun-26-18 02:44PM  Simply Wall St.]
▶ Cutera to Present at Jefferies Global Healthcare Conference   [May-15-18 07:30AM  GlobeNewswire]
▶ Cutera: 1Q Earnings Snapshot   [May-08-18 07:22PM  Associated Press]
▶ Cutera, Inc. to Announce First Quarter 2018 Results   [Apr-11-18 07:30AM  GlobeNewswire]
▶ 10 Healthcare Stocks to Stave Off the Market Flu   [Apr-06-18 02:23PM  InvestorPlace]
▶ Cutera to Present at Two Upcoming Healthcare Conferences   [Feb-27-18 07:30AM  GlobeNewswire]
▶ Cutera Showcases Expanded Portfolio at AAD   [07:00AM  GlobeNewswire]
▶ Cutera, Inc. to Host Earnings Call   [12:10PM  ACCESSWIRE]
▶ Three Activist Hedge Funds to Watch   [Jan-22-18 07:00PM  TheStreet.com]
▶ ETFs with exposure to Cutera, Inc. : December 27, 2017   [Dec-27-17 11:08AM  Capital Cube]
▶ Cutera Announces Appointment of Sandra Gardiner as CFO   [Dec-04-17 07:30AM  GlobeNewswire]
▶ Cutera posts 3Q profit   [Nov-07-17 05:27PM  Associated Press]
▶ Cutera, Inc. to Host Earnings Call   [10:10AM  ACCESSWIRE]
▶ ETFs with exposure to Cutera, Inc. : October 20, 2017   [Oct-20-17 10:10AM  Capital Cube]
▶ ETFs with exposure to Cutera, Inc. : September 29, 2017   [Sep-29-17 10:25AM  Capital Cube]
▶ Have Investors Already Priced In Cutera Incs (CUTR) Growth?   [Sep-21-17 08:51AM  Simply Wall St.]
▶ [$$] Cutera Set to Face Tougher Comps   [Sep-18-17 01:48PM  Barrons.com]
▶ ETFs with exposure to Cutera, Inc. : September 14, 2017   [Sep-14-17 06:08PM  Capital Cube]
▶ Is Cutera (CUTR) a Great Growth Stock?   [Aug-25-17 08:46AM  Zacks]
▶ Cutera posts 2Q profit   [Aug-07-17 11:49PM  Associated Press]
▶ Cutera to Host Analyst & Investor Day on June 14, 2017   [Jun-08-17 07:30AM  GlobeNewswire]
▶ ETFs with exposure to Cutera, Inc. : June 2, 2017   [Jun-02-17 02:00PM  Capital Cube]
▶ ETFs with exposure to Cutera, Inc. : May 4, 2017   [May-04-17 03:51PM  Capital Cube]
▶ Cutera reports 1Q loss   [May-01-17 05:06PM  Associated Press]
▶ ETFs with exposure to Cutera, Inc. : April 17, 2017   [Apr-17-17 12:51PM  Capital Cube]
▶ ETFs with exposure to Cutera, Inc. : April 5, 2017   [Apr-05-17 04:36PM  Capital Cube]
▶ Cutera to Present at the 29th Annual ROTH Conference   [Feb-28-17 07:30AM  GlobeNewswire]
▶ Why Cutera (CUTR) Stock Might be a Great Pick   [Feb-17-17 08:48AM  Zacks]
▶ Cutera posts 4Q profit   [Feb-13-17 06:01PM  Associated Press]
Financial statements of CUTR
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.